Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

8.67
-0.1700-1.92%
Volume:347.65K
Turnover:3.01M
Market Cap:1.36B
PE:-2.74
High:8.76
Open:8.75
Low:8.58
Close:8.84
52wk High:10.94
52wk Low:4.16
Shares:157.00M
Float Shares:107.00M
Volume Ratio:0.65
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1619
EPS(LYR):-3.1619
ROE:-45.73%
ROA:-24.36%
PB:1.78
PE(LYR):-2.74

Loading ...

Vanina de Verneuil, EVP and General Counsel, Reports Sale of Vir Biotechnology Common Shares

Reuters
·
Nov 08, 2025

Vir Biotechnology to Present at Jefferies London Healthcare Conference

Reuters
·
Nov 07, 2025

Evercore ISI Remains a Buy on Vir Biotechnology (VIR)

TIPRANKS
·
Nov 06, 2025

Bank of America Securities Sticks to Their Buy Rating for Vir Biotechnology (VIR)

TIPRANKS
·
Nov 06, 2025

Vir Biotechnology misses Q3 revenue estimates

Reuters
·
Nov 06, 2025

Vir Biotechnology Q3 EPS $(1.17) Misses $(0.84) Estimate, Sales $240.000K Miss $1.983M Estimate

Benzinga
·
Nov 06, 2025

Vir Biotechnology Reports Strong Q3 Results and Advances Clinical Pipeline

Reuters
·
Nov 06, 2025

BRIEF-Vir Biotechnology Q3 EPS USD -1.17

Reuters
·
Nov 06, 2025

Director Vicki L. Sato Reports Sale of Vir Biotechnology Inc. Common Shares

Reuters
·
Nov 05, 2025

Vir Biotechnology Inc expected to post a loss of 85 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Vir Biotechnology completes enrollment in ECLIPSE 1 trial

TIPRANKS
·
Nov 03, 2025

Vir Biotechnology Announces Completion of Enrollment in Eclipse 1 Phase 3 Trial for Chronic Hepatitis Delta

THOMSON REUTERS
·
Nov 03, 2025

Vir Biotechnology Inc - Eclipse 1 Primary Completion Expected Q4 2026

THOMSON REUTERS
·
Nov 03, 2025

SVF Endurance (Cayman) Ltd Reports Disposal of Vir Biotechnology Inc. Common Shares

Reuters
·
Oct 29, 2025

H.C. Wainwright Sticks to Its Buy Rating for Vir Biotechnology (VIR)

TIPRANKS
·
Oct 28, 2025

Press Release: Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025

Dow Jones
·
Oct 23, 2025

SVF Endurance (Cayman) Ltd Reports Disposal of Vir Biotechnology Inc. Common Shares

Reuters
·
Oct 23, 2025

Recent uptick might appease Vir Biotechnology, Inc. (NASDAQ:VIR) institutional owners after losing 18% over the past year

Simply Wall St.
·
Oct 22, 2025

Vir Biotechnology (VIR) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Oct 15, 2025

SVF Endurance (Cayman) Ltd. Reports Disposal of Common Shares of Vir Biotechnology Inc

Reuters
·
Oct 15, 2025